Image of Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor

LITERATURE

Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor


We describe a type 2 diabetes patient with persistent hypoglycemia caused by sulfonylurea
misuse on top of a DPP-4 inhibitor. Hyperinsulinemia was exaggerated by dextrose administration,
but was successfully treated with octreotide. Since many patients are currently
treated with DPP-4 inhibitors, the importance of octreotide has been increasing. For
refractory sulfonylurea-induced hypoglycemia, especially when the patient is also being
given an incretin-based therapy, octreotide should be considered


Availability

REQJ335-01Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
D i a b R e s C l i n P r a c
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous